Nrf2 is considered a promising therapeutic target to control global oxidative stress in neurodegenerative brain diseases including AD because its activation initiates the expression of key endogenous antioxidant and detoxicating enzymes to counteract oxidative stress and regain redox homeostasis (1). Here, NFE2L2 is linked to Alzheimer disease.